You are here

Article Text

Article menu
Download PDFPDF
Standards
Standard and Guidelines: Intracranial Dural Arteriovenous Shunts

https://doi.org/10.1136/neurintsurg-2015-012116

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Contributors All authors contributed to this manuscript.

    • Competing interests SWH: royalty agreement: Penumbra (ChemoFilter); consultant: Stryker Neurovascular, Silk Road Medical, Medina Medical; research grants: NIH-NCI, NIH-NIBIB, Siemens Medical. AA: investor: Lazarus Effect, Valor Medical; research support: Siemens, Sequent, Codman; consultant; Codman, Medtronic, MicroVention, Penumbra, Sequent, Silk Road, Stryker. BB: consultant/speakers bureau: Penumbra, Stryker, Medtronic, Pulsar. JEDA: consultant: Medtronic Neurovascular. DF: consultant: MicroVention, Stryker, Medtronic, Penumbra, Siemens. CP: consultant: Stryker Neurovascular, Codman Neurovascular, Edge Threrapeutics; consultant and shareholder: Thermopeutix; board member: International Brain Research Foundation. GLP: consultant: Sequent Medical. PR: investor and scientific advisory board: Perflow Medical, Blockade Medical; scientific advisory board member: Medtronic Neurovascular, Stryker Neurovascular.

    • Provenance and peer review Commissioned; internally peer reviewed.

    Linked Articles